Lys Therapeutics Raises More Than €25 Million to Advance LYS241 Toward Clinical Development in Neurology
Financing includes a grant of more than $5 million from The Michael J. Fox Foundation to advance a first-in-class neurovascular antibody across major neurological indicationsLYON and CAEN, France, June 22, 2026 /PRNewswire/ — Lys Therapeutics, a French biotechnology company…
News provided by PR Newswire.
